To perform this analysis, scRNA-seq clusters containing CD14+ monocytes from both mild and moderate subjects were merged were appropriate (Supplemental Methods) and two published datasets were incorporated to enable comparison with more severe COVID-19 disease phenotypes16,17. Here, CD14 is linked to COVID-19.